Repeated administration of (-) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions

Maurizio Memo, Marina Pizzi, Enzo Nisoli, Cristina Missale, Michele O. Carruba, Pierfranco Spano

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

We studied the possible function modifications of both D-1 and D-2 dopamine (DA) receptor subtypes following repeated administration of DA antagonists that act selectively on a single class of DA receptors. The functional state of D-1 and D-2 DA receptors in particular was evaluated by measuring SKF 82526-stimulated and bromocriptine-inhibited adenylate cyclase activity in different brain regions of rats treated with saline, SCH 23390, or (-)sulpiride for 21 days. The results indicate that chronic blockade of D-1 DA receptors in striatum, nucleus accumbens, and substantia nigra by SCH 23390 induced up-regulation of the D-1 receptors without changing the functional activity of D-2 receptors. Likewise, chronic blockade of D-2 DA receptors by (-) sulpiride caused up-regulation of D-2 but not D-1 DA receptors in striatum, nucleus accumbens, substantia nigra and pituitary. SCH 23390 or (-)sulpiride did not modify the functional activity of either D-1 or D-2 DA receptors located in frontal cortex and hippocampus. In conclusion, these results indicate that chronic treatment with selective D-1 or D-2 DA receptor blockers induces a receptor-specific up-regulation which involves the DA receptors located in the nigrostriatal system and pituitary but not those in the limbic-cortical areas.

Original languageEnglish
Pages (from-to)45-51
Number of pages7
JournalEuropean Journal of Pharmacology
Volume138
Issue number1
DOIs
Publication statusPublished - Jun 12 1987

Fingerprint

Sulpiride
Dopamine Receptors
Up-Regulation
Brain
Dopamine Antagonists
Nucleus Accumbens
Substantia Nigra
Fenoldopam
SCH 23390
Bromocriptine
Frontal Lobe
Adenylyl Cyclases
Hippocampus

Keywords

  • (-)Sulpiride
  • (Up-regulation)
  • Adenylate cyclase
  • D-1 dopamine receptors
  • D-2 dopamine receptors
  • SCH 23390

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Repeated administration of (-) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions. / Memo, Maurizio; Pizzi, Marina; Nisoli, Enzo; Missale, Cristina; Carruba, Michele O.; Spano, Pierfranco.

In: European Journal of Pharmacology, Vol. 138, No. 1, 12.06.1987, p. 45-51.

Research output: Contribution to journalArticle

Memo, Maurizio ; Pizzi, Marina ; Nisoli, Enzo ; Missale, Cristina ; Carruba, Michele O. ; Spano, Pierfranco. / Repeated administration of (-) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions. In: European Journal of Pharmacology. 1987 ; Vol. 138, No. 1. pp. 45-51.
@article{0cf142d55d5247339050e39be8c63354,
title = "Repeated administration of (-) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions",
abstract = "We studied the possible function modifications of both D-1 and D-2 dopamine (DA) receptor subtypes following repeated administration of DA antagonists that act selectively on a single class of DA receptors. The functional state of D-1 and D-2 DA receptors in particular was evaluated by measuring SKF 82526-stimulated and bromocriptine-inhibited adenylate cyclase activity in different brain regions of rats treated with saline, SCH 23390, or (-)sulpiride for 21 days. The results indicate that chronic blockade of D-1 DA receptors in striatum, nucleus accumbens, and substantia nigra by SCH 23390 induced up-regulation of the D-1 receptors without changing the functional activity of D-2 receptors. Likewise, chronic blockade of D-2 DA receptors by (-) sulpiride caused up-regulation of D-2 but not D-1 DA receptors in striatum, nucleus accumbens, substantia nigra and pituitary. SCH 23390 or (-)sulpiride did not modify the functional activity of either D-1 or D-2 DA receptors located in frontal cortex and hippocampus. In conclusion, these results indicate that chronic treatment with selective D-1 or D-2 DA receptor blockers induces a receptor-specific up-regulation which involves the DA receptors located in the nigrostriatal system and pituitary but not those in the limbic-cortical areas.",
keywords = "(-)Sulpiride, (Up-regulation), Adenylate cyclase, D-1 dopamine receptors, D-2 dopamine receptors, SCH 23390",
author = "Maurizio Memo and Marina Pizzi and Enzo Nisoli and Cristina Missale and Carruba, {Michele O.} and Pierfranco Spano",
year = "1987",
month = "6",
day = "12",
doi = "10.1016/0014-2999(87)90335-9",
language = "English",
volume = "138",
pages = "45--51",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Repeated administration of (-) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions

AU - Memo, Maurizio

AU - Pizzi, Marina

AU - Nisoli, Enzo

AU - Missale, Cristina

AU - Carruba, Michele O.

AU - Spano, Pierfranco

PY - 1987/6/12

Y1 - 1987/6/12

N2 - We studied the possible function modifications of both D-1 and D-2 dopamine (DA) receptor subtypes following repeated administration of DA antagonists that act selectively on a single class of DA receptors. The functional state of D-1 and D-2 DA receptors in particular was evaluated by measuring SKF 82526-stimulated and bromocriptine-inhibited adenylate cyclase activity in different brain regions of rats treated with saline, SCH 23390, or (-)sulpiride for 21 days. The results indicate that chronic blockade of D-1 DA receptors in striatum, nucleus accumbens, and substantia nigra by SCH 23390 induced up-regulation of the D-1 receptors without changing the functional activity of D-2 receptors. Likewise, chronic blockade of D-2 DA receptors by (-) sulpiride caused up-regulation of D-2 but not D-1 DA receptors in striatum, nucleus accumbens, substantia nigra and pituitary. SCH 23390 or (-)sulpiride did not modify the functional activity of either D-1 or D-2 DA receptors located in frontal cortex and hippocampus. In conclusion, these results indicate that chronic treatment with selective D-1 or D-2 DA receptor blockers induces a receptor-specific up-regulation which involves the DA receptors located in the nigrostriatal system and pituitary but not those in the limbic-cortical areas.

AB - We studied the possible function modifications of both D-1 and D-2 dopamine (DA) receptor subtypes following repeated administration of DA antagonists that act selectively on a single class of DA receptors. The functional state of D-1 and D-2 DA receptors in particular was evaluated by measuring SKF 82526-stimulated and bromocriptine-inhibited adenylate cyclase activity in different brain regions of rats treated with saline, SCH 23390, or (-)sulpiride for 21 days. The results indicate that chronic blockade of D-1 DA receptors in striatum, nucleus accumbens, and substantia nigra by SCH 23390 induced up-regulation of the D-1 receptors without changing the functional activity of D-2 receptors. Likewise, chronic blockade of D-2 DA receptors by (-) sulpiride caused up-regulation of D-2 but not D-1 DA receptors in striatum, nucleus accumbens, substantia nigra and pituitary. SCH 23390 or (-)sulpiride did not modify the functional activity of either D-1 or D-2 DA receptors located in frontal cortex and hippocampus. In conclusion, these results indicate that chronic treatment with selective D-1 or D-2 DA receptor blockers induces a receptor-specific up-regulation which involves the DA receptors located in the nigrostriatal system and pituitary but not those in the limbic-cortical areas.

KW - (-)Sulpiride

KW - (Up-regulation)

KW - Adenylate cyclase

KW - D-1 dopamine receptors

KW - D-2 dopamine receptors

KW - SCH 23390

UR - http://www.scopus.com/inward/record.url?scp=0023216082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023216082&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(87)90335-9

DO - 10.1016/0014-2999(87)90335-9

M3 - Article

C2 - 2887436

AN - SCOPUS:0023216082

VL - 138

SP - 45

EP - 51

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -